Get the Stockscreener App
3.06
0.97%
-0.03
Evolent Health Inc stock is traded at $3.06, with a volume of 2.49M.
It is down -0.97% in the last 24 hours and down -21.34% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$3.09
Open:
$3.09
24h Volume:
2.49M
Relative Volume:
0.66
Market Cap:
$341.50M
Revenue:
$2.05B
Net Income/Loss:
$-128.18M
P/E Ratio:
-1.9495
EPS:
-1.5696
Net Cash Flow:
$-68.67M
1W Performance:
-5.26%
1M Performance:
-21.34%
6M Performance:
-68.68%
1Y Performance:
-70.15%
1-Day Range:
$3.005
$3.175
1-Week Range:
$3.005
$3.43
52-Week Range:
$3.005
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.06 | 344.85M | 2.05B | -128.18M | -68.67M | -1.5696 |
|
VEEV
Veeva Systems Inc
|
190.69 | 31.36B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.55 | 9.96B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
81.34 | 7.02B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.28 | 7.04B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
35.25 | 6.56B | 550.17M | 201.35M | 232.07M | 1.00 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 - Finviz
Support Test: Is Evolent Health Inc affected by consumer sentiment2025 Momentum Check & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Evolent Health to offer $140M in convertible notes, Targets 2025 debt, stock buyback - MSN
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist - Yahoo Finance
Evolent Health price target lowered to $10 from $16 at BTIG - TipRanks
Deep Dive Into Evolent Health Stock: Analyst Perspectives (11 Ratings) - Benzinga
Evolent Health (EVH) Price Target Lowered to $10 by BTIG | EVH S - GuruFocus
Income Plays: What is Evolent Health Inc. s 5 year growth outlookStop Loss & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Final Week: What is the next catalyst for Evolent Health Inc.Inflation Watch & Short-Term High Return Strategies - mfd.ru
Evolent Health (NYSE:EVH) Focus Amid Nyse Composite Turbulence And Sector Pressure - Kalkine Media
Evolent Health (NYSE:EVH) Use Of Debt Could Be Considered Risky - 富途牛牛
Take Care Before Diving Into The Deep End On Evolent Health, Inc. (NYSE:EVH) - simplywall.st
Evolent Health, Inc. (EVH) Stock Analysis: Navigating a 147% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews
Evolent Health Announces Leadership Changes Amid Growth - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50 Day Moving AverageHere's What Happened - MarketBeat
Price-Driven Insight from (EVH) for Rule-Based Strategy - Stock Traders Daily
Ideas Watch: Is Evolent Health Inc a speculative investmentJuly 2025 Analyst Calls & Reliable Intraday Trade Plans - baoquankhu1.vn
Gains Recap: Is Evolent Health Inc affected by consumer sentimentNew Guidance & Risk Controlled Swing Alerts - baoquankhu1.vn
Earnings Recap: Is Central Plains Bancshares Inc forming a breakout patternJuly 2025 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn
Evolent Health (EVH): Can This Healthcare Innovator Deliver A 154% Upside? - DirectorsTalk Interviews
Gains Recap: Is Evolent Health Inc currently under institutional pressureEarnings Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Aug Outlook: How sensitive is Evolent Health Inc to inflationJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
Shorts Report: Whats next for Evolent Health Inc stock2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
Market Wrap: Will Alvotech benefit from government policyJuly 2025 Reactions & Verified Entry Point Detection - baoquankhu1.vn
Canaccord cuts Evolent Health target to $16, maintains Buy - MSN
Signal Recap: Is now the right time to enter Evolent Health IncJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
From Pilot to Program: Florida Blue Expands Cancer Support for Medicare Advantage Members - Florida Hospital News and Healthcare Report
Evolent Health (EVH) Price Target Decreased by 10.18% to 9.33 - Nasdaq
Market Fear: How Evolent Health Inc stock valuations compare to rivalsWeekly Trend Recap & Daily Profit Maximizing Tips - Bộ Nội Vụ
Loss Report: Will Evolent Health Inc stock recover faster than marketDividend Hike & Advanced Swing Trade Entry Alerts - Bộ Nội Vụ
Evolent Health, Inc. (EVH) Stock Analysis: A 131% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews
(EVH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Evolent Health (EVH) Q1 Earnings Lag Estimates - sharewise.com
Does Evolent Health Inc. stock trade at a discount to peersQuarterly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
How Evolent Health Inc. stock reacts to inflationary pressures2025 Volatility Report & Step-by-Step Swing Trade Plans - ulpravda.ru
Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth - MSN
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Citigroup Lowers Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Aug Wrap: How Evolent Health Inc. stock reacts to bond yieldsTrend Reversal & Long-Term Growth Portfolio Plans - Улправда
Quarterly Earnings: How Evolent Health Inc stock reacts to job market dataQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Bộ Nội Vụ
Entry Recap: How Evolent Health Inc. stock reacts to job market dataMarket Volume Report & Technical Pattern Recognition Alerts - Улправда
Setup Watch: How Evolent Health Inc. stock reacts to inflationary pressures2025 Investor Takeaways & Fast Gain Swing Alerts - ulpravda.ru
How sustainable is Evolent Health Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
How Evolent Health Inc. stock reacts to bond yieldsCPI Data & Fast Entry Momentum Trade Alerts - Улправда
How Evolent Health Inc. stock reacts to job market dataPortfolio Growth Summary & High Conviction Trade Alerts - ulpravda.ru
Insider Stock Buying Reaches US$1.38m On Evolent Health - Yahoo Finance
Is the options market predicting a spike in Evolent Health stock? - MSN
Evolent Health (EVH) Analyst Maintains Rating, Lowers Price Targ - GuruFocus
Evolent Health, Inc. (EVH) Stock Analysis: Can a 155% Upside Propel This Healthcare Innovator? - DirectorsTalk Interviews
Citizens lowers Evolent Health stock price target on ACA membership concerns - Investing.com Canada
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):